Back

Design of the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)

22 May 2023 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 2 Heart Transplantation HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Kaspar Broch

Oslo University Hospital Rikshospitalet, Oslo (Norway)

7 More presentations in this session

Presentation thumbnail
Acute kidney failure after heart transplantation, Risk factors and clinical outcome
Doctor F. Welz (Berlin, DE)
Abstract Slides
Presentation thumbnail
Long-term transesophageal echocardiographic characterization of flow dynamics of the V-Wave Ventura Interatrial Shunt device in patients with advanced heart failure
Professor J. Bax (Leiden, NL)
Abstract Slides
Presentation thumbnail
The predictive role of absolute lymphocyte counts for fatal infection in heart transplantation recipients who received induction therapy
Doctor J. Oh (Seoul, KR)
Abstract Slides
Presentation thumbnail
Preoperative neutrophil-to-lymphocyte ratio as a predictor of primary graft dysfunction and prognosis after heart transplantation
Doctor C. Millan Rodriguez (Sevilla, Spain, ES)
Abstract Slides
Presentation thumbnail
Clinical relevance and outcome of routine endomyocardial biopsy to detect rejection after heart transplantation
Mr L. Kieviet (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - treatment 2

The Event

Event poster

Heart Failure 2023

22 May 2023 10:00 CET
You may be interested in
thumbnail
Congress Session
Advanced heart failure, mechanical circulatory support, and transplant
thumbnail
Congress Session
The strength of scientific integration
thumbnail
Congress Session
Navigating through heart failure device therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources